ENTITY
JD Health International

JD Health International (6618 HK)

372
Analysis
Consumer StaplesChina
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
09 Feb 2021 07:49

HSI Market Consultation - Name Changes as We Await the Conclusions

The conclusions of the HSI market consultation could be announced on 26 Feb along with the March review. Given recent large listings and price...

Logo
563 Views
Share
04 Feb 2021 17:27

Kuaishou IPO: Trading Debut

Kuaishou priced its IPO at HK$115 and the grey market price last stood at HK$278. Our DCF sensitivity analysis shows that the grey market price is...

Logo
473 Views
Share
02 Feb 2021 07:24

HSCEI Index Rebalances - The Year of the Ox and of More Change

There will be a lot of changes to the HSCEI this year that will impact the sectoral composition and open up trading opportunities on the stocks and...

Logo
673 Views
Share
01 Feb 2021 21:54

Kuaishou IPO: Is It Worth Twice the IPO Price?

Kuaishou's grey market price has hit HK$250 per share, slightly more than 2x the IPO price of HK$115. Our analysis suggests that this valuation can...

Logo
434 Views
Share
bullishM3 Inc
01 Feb 2021 09:00

M3 3Q Results: Strong Growth in Earnings Driven by Medical and Overseas Businesses

M3 Inc. reported its 3QFY03/2021 results on Friday (29th January 2021) which saw both revenues and OP increasing at 40.1% and 78.5% YoY during the...

Share
x